Tranexamic Acid
- Product NDC
- 70860-407
- 11-digit product format
- 708600407
- Labeler code
- 70860
- Product ID
- 70860-407_3b4ac37a-424b-4e95-b65b-22e2a85d12b3
- Type
- HUMAN PRESCRIPTION DRUG
- Nonproprietary name
- tranexamic acid
- Dosage form
- INJECTION, SOLUTION
- Route
- INTRAVENOUS
- Labeler
- Athenex Pharmaceutical Division, LLC.
- Application
- ANDA203521
- Marketing category
- ANDA
- Marketing start
- 2022-09-22
- Marketing end
- 0000-00-00
- Substance
- TRANEXAMIC ACID
- Active strength
- 100 mg/mL
- Pharmacologic classes
- Antifibrinolytic Agent [EPC], Decreased Fibrinolysis [PE]
- NDC exclude flag
- No
- Listing certified through
- 2023-12-31
- Current FDA listing
- Historical FDA.report record
DailyMed Dashboard NDC Coverage#
NDC, Dashboard title, SPL version table| NDC | Dashboard title | SPL version | Validation | Dashboard ZIP |
|---|
| 70860-407 | TRANEXAMIC ACID INJECTION, SOLUTION [ATHENEX PHARMACEUTICAL DIVISION, LLC.] | 3 | Legacy NDC | 20231223_c564239a-bf25-4fde-9715-2998512dd097.zip |
Packages#
Package NDC, 11-digit format, Description table| Package NDC | 11-digit format | Description | Marketing start | Marketing end | Sample | Exclude flag | Status |
|---|
| 70860-407-10 | 70860040710 | 10 VIAL, SINGLE-DOSE in 1 CARTON (70860-407-10) > 10 mL in 1 VIAL, SINGLE-DOSE (70860-407-41) | 2022-09-22 | 0000-00-00 | No | No | Current |